Acta Scientific Microbiology

Research ArticleVolume 1 Issue 9

Treatment of Acute Respiratory Viral Infections of the Human Polarized Polychromatic Incoherent Light

Divocha VA

Lugansk State Medical University, Rubezhoe, Ukraine

*Corresponding Author: Divocha VA, Lugansk State Medical University, Rubezhoe, Ukraine.

Received: July 17, 2018; Published: August 24, 2018

Citation: Divocha VA. “Treatment of Acute Respiratory Viral Infections of the Human Polarized Polychromatic Incoherent Light”. Acta Scientific Microbiology 1.9 (2018).


  In the article the literature data and own studies on improving the method of treatment of influenza and SARS in humans by using polarized light, which is aimed at inflammatory sites with influenza virus (SARS) and prevention of hazardous heavy complications.

Keywords: Polarized Light; Treatment of Influenza Virus and SARS

Copyright: © 2018 Divocha VA. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Member In

News and Events

  • Special Issue on Reviews
    Acta Scientific Journals has been started Special Issue on Reviews, researchers from world wide welcoming for submission of their reviews on any topic by on/ before August 30, 2019. Special Issue is going to be released on September 10, 2019
  • Submission Timeline for Regular Issue
    Last date for submission of articles is September 05, 2019.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US